What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
His primary areas of investigation include Endocrinology, Internal medicine, Glycation, Pentosidine and Biochemistry.
His research in Endocrinology intersects with topics in Methylglyoxal and Peritoneal dialysis.
His Internal medicine study frequently links to adjacent areas such as Diabetes mellitus.
His Glycation research includes elements of Malondialdehyde, Uremia and Amyloidosis.
Toshio Miyata interconnects Diabetic nephropathy, Renal function, Maillard reaction, Hemodialysis and Advanced glycation end-product in the investigation of issues within Pentosidine.
His research integrates issues of Hypoxia, Hypoxia-inducible factors, Kidney disease, Nephropathy and Pathology in his study of Kidney.
His most cited work include:
- Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. (806 citations)
- Protein-bound acrolein: Potential markers for oxidative stress (531 citations)
- Alterations in nonenzymatic biochemistry in uremia: Origin and significance of “carbonyl stress” in long-term uremic complications (469 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Endocrinology, Glycation, Biochemistry and Pentosidine.
His study looks at the relationship between Internal medicine and topics such as Diabetes mellitus, which overlap with Gastroenterology.
His study in Oxidative stress, Kidney disease, Hypoxia, Angiotensin II and Nitric oxide is done as part of Endocrinology.
His Glycation study also includes
- Uremia which intersects with area such as Dialysis,
- Amyloidosis which connect with Amyloid.
His biological study spans a wide range of topics, including Glyoxal and Peritoneal dialysis.
His Pentosidine study frequently draws connections between adjacent fields such as Malondialdehyde.
He most often published in these fields:
- Internal medicine (56.78%)
- Endocrinology (50.57%)
- Glycation (36.32%)
What were the highlights of his more recent work (between 2012-2021)?
- Internal medicine (56.78%)
- Endocrinology (50.57%)
- Plasminogen activator inhibitor-1 (8.97%)
In recent papers he was focusing on the following fields of study:
Toshio Miyata mainly focuses on Internal medicine, Endocrinology, Plasminogen activator inhibitor-1, Plasminogen activator and Cancer research.
His Internal medicine study incorporates themes from Diabetes mellitus, Schizophrenia and Gastroenterology.
The study of Endocrinology is intertwined with the study of Methylglyoxal in a number of ways.
His Plasminogen activator study combines topics in areas such as Apoptosis, Senescence, Antagonist, Pharmacology and In vivo.
His Cancer research research is multidisciplinary, incorporating elements of Haematopoiesis, Inflammation, Immunology, Bone marrow and Molecular biology.
His study on Pentosidine is covered under Biochemistry.
Between 2012 and 2021, his most popular works were:
- Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis (292 citations)
- PAI-1–regulated extracellular proteolysis governs senescence and survival in Klotho mice (99 citations)
- Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes (89 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Toshio Miyata focuses on Internal medicine, Plasminogen activator inhibitor-1, Cancer research, Plasminogen activator and Endocrinology.
Toshio Miyata is interested in Pentosidine, which is a branch of Internal medicine.
His Cancer research research incorporates themes from Plasmin, Inflammation, Immunology, Molecular biology and Regeneration.
His study on Plasminogen activator also encompasses disciplines like
- Senescence, which have a strong connection to Biochemistry, Phenotype, Serine protease, Proteolysis and Klotho,
- Cancer together with Matrigel and Viability assay,
- Apoptosis that intertwine with fields like Cell growth.
Many of his studies on Endocrinology apply to Proinflammatory cytokine as well.
Toshio Miyata combines subjects such as Methylglyoxal and Endothelial dysfunction with his study of Glycation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
